⌘K
Loading ticker…
As of 2026-08-24, Gyre Therapeutics, Inc. Common Stock (GYRE) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 0.96×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
GYRE is held by 11 ETFs as of May 2026. Top owner: SCHA at 0.00% weight, $590K notional. Top 3 carry $1M.
Held by 18 ETFs · $11M across latest filings · largest weight 0.02% (EES).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $590K | — |
| VTWO | 0.00% | $355K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $106K | — |
| VTWG | 0.00% | $65K | — |
| AVSC | 0.00% | $11K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $5K |
| — |
| ITWO | 0.00% | $3K | — |
| URTY | 0.00% | $3K | — |
| UWM | 0.00% | $3K | — |
| HDG | 0.00% | $65 | — |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GYRE Jan avg: -14.04% median: -4.88% win: 33% σ: 34.16% n: 3 2023-11-01 → 2026-07-31 | GYRE Feb avg: 16.43% median: 1.85% win: 100% σ: 26.17% n: 3 2023-11-01 → 2026-07-31 | GYRE Mar avg: -17.50% median: -15.41% win: 0% σ: 15.01% n: 3 2023-11-01 → 2026-07-31 | GYRE Apr avg: 8.62% median: 10.19% win: 67% σ: 18.64% n: 3 2023-11-01 → 2026-07-31 | GYRE May avg: -19.10% median: -23.05% win: 0% σ: 10.62% n: 3 2023-11-01 → 2026-07-31 | GYRE Jun avg: -0.81% median: 5.02% win: 67% σ: 16.05% n: 3 2023-11-01 → 2026-07-31 | GYRE Jul avg: 1.49% median: -4.08% win: 33% σ: 17.69% n: 3 2023-11-01 → 2026-07-31 | GYRE Aug avg: 2.48% median: 2.48% win: 50% σ: 10.34% n: 2 2023-11-01 → 2026-07-31 (current) | GYRE Sep avg: -6.28% median: -6.28% win: 0% σ: 3.76% n: 2 2023-11-01 → 2026-07-31 | GYRE Oct avg: 8.96% median: 8.96% win: 100% σ: 7.17% n: 2 2023-11-01 → 2026-07-31 | GYRE Nov avg: 78.99% median: 0.00% win: 33% σ: 147.78% n: 3 2023-11-01 → 2026-07-31 | GYRE Dec avg: -0.98% median: -3.28% win: 33% σ: 9.28% n: 3 2023-11-01 → 2026-07-31 |